Automation in pharma production: more output without more complexity

ArticlePharma & life sciences insights

6 min read

Discover how targeted, integrated automation can increase pharmaceutical production output, reduce downtime, improve traceability, and make existing lines more flexible, without adding unnecessary complexity or process instability.

Share

Two Körber employee discussing ideas with a tablet in a warehouse setting.

"How do we get more out of our existing line, without introducing new instability into the process?" It's a question we hear in almost every conversation with production leaders across pharma, biotech, and life sciences. The pressure is real: demand is fluctuating more sharply, product portfolios are growing more complex, and requirements for compliance and traceability keep rising.

This is exactly where automation changes the equation, not as a blanket principle of "more machines, more speed," but as a targeted lever applied where processes create the most friction today.

Not "more automation“ but smarter automation

The pressure on pharmaceutical production capacity isn't a temporary phenomenon. Production leaders across the industry report increasingly volatile demand, paired with shrinking tolerance for delivery delays. At the same time, independent analyses of pharmaceutical manufacturing show that unplanned downtime regularly ranks among the costliest operational risks, ahead of material costs or staff turnover. Taking together, these two trends paint a clear picture: manufacturers need to use existing assets more intensively, run them more predictably, and respond faster to shifts in demand, all within a regulatory environment that leaves no room for compromise on quality or documentation.

In this context, automation isn't a technical add-on. It's the foundation that makes it possible to meet all three requirements at once: more output, more predictability, more responsiveness.

The instinctive response to capacity pressure is often to automate individual process steps, a faster filling line, an additional inspection system, and a new robotic solution. That can help. But it rarely solves real problems. In practice, the greatest operational friction doesn't come from individual machines; it comes from what happens between them.

At interfaces and handovers

When product, data, or materials must be handed over manually between process steps, that's where waiting times, error sources, and information loss creep in. A line that's automated on paper but still relies on manual checks at every interface stay limited in its overall performance.

In material flow

What raw materials, packaging materials, and intermediate products move through the line often shapes actual output more than the cycle time of any single machine. Unstructured or manually steered material flow creates bottlenecks that only become visible when you look at the line.

In line integration

When filling, inspection, labeling, and packaging don't work as one connected system but as a sequence of individual machines from different vendors, every format changeover, every disruption, and every maintenance task turn into its own coordination challenge.

At recurring manual process steps

Manual approvals, manual documentation, manual quality checks at predictable points in the process, these are exactly the places where automation has the most immediate impact on cycle time and error rate, because they're repetitive, rule-based, and therefore inherently automatable.

The decisive difference, then, isn't how much automation you apply to it; it's how precisely you apply it at the right points.

What automation delivers for production — in concrete terms

Applied at these leverage points, automation's impact shows up across four dimensions that reinforce each other:

  • Higher output. When interfaces, material flow, and line integration are aligned, effective output rises, often far more than optimizing individual machines ever could.
  • Fewer stoppages and manual interventions. Every manual handover is a potential error point and a potential delay. Automate it, and both downtime and process variability drop.
  • More predictable operations. Automated processes deliver consistent, predictable cycle times. That makes capacity planning more resilient, a real advantage during demand peaks or seasonal swings.
  • Faster response to shifts in demand. A line that's automated and integrated end to end can be retooled, scaled or adapted to a new product format faster than a line that relies on manual coordination at every transition.

That's where the real leverage lies not in a single improvement, but in how everything works together.

What this looks like in practice

One example makes the difference clear. A production line built from separately sourced, independently validated machines for filling, inspection, and packaging works, until a format changeover is needed. Then it becomes clear that each machine has its own control logic, its own data interface, and its own setup time. The changeover takes days instead of hours, because no one designed the full line concept, only as the sum of its parts.

Design that same line from the start as one integrated system, with a unified control architecture, a shared data model for track & trace, and a material flow logic that avoids bottlenecks by design and the picture changes fundamentally. Format changes become a matter of parameter settings, not projects. A disruption at one station triggers automated responses at neighboring stations instead of manual rework. And because inspection data feeds directly into labeling and serialization, the manual checks that used to cost time every single day simply disappear.

Fazit: the leverage is in precision, not volume

The difference isn't the number of technologies deployed. It's whether they were designed as one system or as a collection of individual solutions that happen to sit side by side.

That means assessing your degree of automation not as a blanket target, but against real process data: Where do the longest wait times occur? Where do manual interventions pile up? Where does equipment availability fluctuate the most? These questions, not the appeal of the latest technology, should be the starting point for every automation decision. A partner who thinks about process analysis, machine building, inspection technology, track & trace, and software from one shared system logic can answer these questions across the entire line, not station by station. What matters most isn't who supplies the technology; it's whether control logic, data model, and accountability for the line are designed together from day one.

Automation is not an end. Its value doesn't come from automating as many process steps as possible; it comes from automating the right process steps: the ones creating the most operational friction today. For manufacturers under growing capacity pressure, that's not an academic distinction. It's the difference between an investment that reduces complexity and one that unintentionally adds to it.

More output without more complexity is possible when automation is applied, where it makes the biggest difference.


Want to find out where automation can make the biggest difference in your production? Talk to our production process experts from process analysis to line integration and implementation.

Get to know our authors

Kevin Hillmann, Chief Digital Officer at Körber Business Area Pharma

Kevin Hillmann

Head of Business Development, Körber Business Area Pharma

FAQ

What industry leaders need to know about automation in pharma

Körber employee smiling

Connect with us

Let’s talk about future-ready solutions for your business.

Contact